Regional Analysis

Global Diabetic Foot Ulcers Treatment Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global diabetic foot ulcers treatment market over the forecast period. North America is estimated to hold 39.9% of the market share in 2023. The global diabetic foot ulcers treatment market is expected to witness significant growth in the coming years, driven by the high prevalence of diabetic foot ulcers. Approximately 2 million Americans develop diabetic foot ulcers each year. Within 5 years of ulceration, over 50% die, and 5% lose a limb. Diabetic foot ulcers cost the U.S. healthcare system US$ 130 billion annually, require significant patient self-management in terms of daily wound care and ambulation restrictions, and can result in devastating function impacts if a major (above- or below-knee) amputation is required. Patients often fear major amputation from diabetic foot ulcers more than death.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa